Michael S. Blaiss

12.5k total citations
174 papers, 4.5k citations indexed

About

Michael S. Blaiss is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael S. Blaiss has authored 174 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Physiology, 96 papers in Immunology and Allergy and 57 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael S. Blaiss's work include Asthma and respiratory diseases (116 papers), Allergic Rhinitis and Sensitization (94 papers) and Respiratory and Cough-Related Research (48 papers). Michael S. Blaiss is often cited by papers focused on Asthma and respiratory diseases (116 papers), Allergic Rhinitis and Sensitization (94 papers) and Respiratory and Cough-Related Research (48 papers). Michael S. Blaiss collaborates with scholars based in United States, United Kingdom and Denmark. Michael S. Blaiss's co-authors include Eli O. Meltzer, Mark A. Wingertzahn, M. Jennifer Derebery, Stuart Stoloff, Todd A. Mahr, Hendrik Nolte, David P. Skoner, John Boyle, Giorgio Walter Canonica and Bruce R. Gordon and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Michael S. Blaiss

162 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael S. Blaiss United States 37 3.0k 2.8k 1.2k 888 492 174 4.5k
John Oppenheimer United States 35 2.9k 1.0× 3.3k 1.2× 1.2k 1.0× 1.5k 1.6× 241 0.5× 136 5.4k
Roy Gerth van Wijk Netherlands 39 3.0k 1.0× 4.3k 1.6× 864 0.7× 1.9k 2.2× 376 0.8× 165 5.5k
Gianenrico Senna Italy 40 2.9k 1.0× 4.2k 1.5× 1.2k 1.0× 1.6k 1.8× 155 0.3× 279 6.8k
Fulvio Braido Italy 33 2.3k 0.8× 1.1k 0.4× 1.9k 1.6× 461 0.5× 159 0.3× 180 4.2k
Robert A. Barbee United States 30 3.9k 1.3× 2.0k 0.7× 2.6k 2.2× 611 0.7× 90 0.2× 57 5.5k
Eli O. Meltzer United States 58 8.2k 2.7× 7.4k 2.7× 3.3k 2.8× 1.5k 1.7× 1.8k 3.6× 293 11.0k
E. Rand Sutherland United States 36 4.6k 1.5× 1.0k 0.4× 3.3k 2.7× 461 0.5× 60 0.1× 62 6.6k
Cheryl M. Salome Australia 43 4.7k 1.5× 987 0.4× 4.2k 3.5× 225 0.3× 84 0.2× 93 6.3k
Gary S. Rachelefsky United States 35 1.9k 0.6× 804 0.3× 1.5k 1.3× 125 0.1× 92 0.2× 129 3.8k
Agustin Calatroni United States 36 2.9k 1.0× 1.7k 0.6× 1.5k 1.3× 548 0.6× 30 0.1× 89 5.0k

Countries citing papers authored by Michael S. Blaiss

Since Specialization
Citations

This map shows the geographic impact of Michael S. Blaiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Blaiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Blaiss more than expected).

Fields of papers citing papers by Michael S. Blaiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Blaiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Blaiss. The network helps show where Michael S. Blaiss may publish in the future.

Co-authorship network of co-authors of Michael S. Blaiss

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Blaiss. A scholar is included among the top collaborators of Michael S. Blaiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Blaiss. Michael S. Blaiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pfaar, Oliver, Ralph Mösges, Michael S. Blaiss, et al.. (2025). The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence‐Based Approach. Allergy. 80(12). 3369–3376.
2.
Smith, John A., Surinder S. Birring, Michael S. Blaiss, et al.. (2025). Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE). American Journal of Respiratory and Critical Care Medicine. 211(6). 1038–1048. 4 indexed citations
3.
Mohan, Vivek, Yifei Ma, P G Gopi, et al.. (2025). The Influence of Nasal Cavity Dimensions on Frequency of Treatment for Rhinitis Symptoms. International Forum of Allergy & Rhinology. 15(12). 1436–1438.
4.
Blaiss, Michael S., Stephen R. Durham, David I. Bernstein, et al.. (2024). Sublingual Tablet Immunotherapy Improves Quality of Life in Adults With Allergic Rhinoconjunctivitis. The Journal of Allergy and Clinical Immunology In Practice. 12(6). 1520–1529.e5. 3 indexed citations
5.
Marshall, Gailen D., Michael S. Blaiss, Daniel Ein, et al.. (2020). Risk of physician burnout in the North American allergist-immunologist workforce. Annals of Allergy Asthma & Immunology. 125(3). 235–243. 3 indexed citations
6.
Abella, Benjamin S., William E. Berger, Michael S. Blaiss, et al.. (2020). Intravenous Cetirizine Versus Intravenous Diphenhydramine for the Treatment of Acute Urticaria: A Phase III Randomized Controlled Noninferiority Trial. Annals of Emergency Medicine. 76(4). 489–500. 11 indexed citations
7.
Hébert, Jacques, Michael S. Blaiss, Susan Waserman, et al.. (2014). The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children. Allergy Asthma and Clinical Immunology. 10(1). 53–53. 4 indexed citations
8.
Colice, Gene, Nancy K. Ostrom, David E. Geller, et al.. (2012). The CHOICE survey: high rates of persistent and uncontrolled asthma in the United States. Annals of Allergy Asthma & Immunology. 108(3). 157–162.e1. 35 indexed citations
9.
Meltzer, Eli O., Michael S. Blaiss, M. Jennifer Derebery, et al.. (2009). Burden of allergic rhinitis: Results from the Pediatric Allergies in America survey. Journal of Allergy and Clinical Immunology. 124(3). S43–S70. 406 indexed citations
10.
11.
Legorreta, Antonio P., Michael S. Blaiss, Eric C. Schneider, et al.. (2004). The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. Annals of Allergy Asthma & Immunology. 93(6). 538–545. 46 indexed citations
12.
Blaiss, Michael S.. (2003). Medical and economic dimensions linking allergic rhinitis and asthma.. PubMed. 23(4). 223–7. 4 indexed citations
13.
Casale, Thomas B., Michael S. Blaiss, Erwin W. Gelfand, et al.. (2003). First do no harm: Managing antihistamine impairment in patients with allergic rhinitis. Journal of Allergy and Clinical Immunology. 111(5). S835–S842. 95 indexed citations
14.
Stempel, David A., Søren Pedersen, & Michael S. Blaiss. (2002). Inhaled Corticosteroids and Growth. How big a dose of caution?. University of Southern Denmark Research Portal (University of Southern Denmark). 1 indexed citations
15.
Blaiss, Michael S.. (1996). The Role of Outcome Studies in Allergy and Clinical Immunology. Allergy and Asthma Proceedings. 17(6). 355–358. 6 indexed citations
16.
Charous, B.Lauren, Emil J. Bardana, Michael S. Blaiss, et al.. (1995). Latex allergy - An emerging healthcare problem. Annals of Allergy Asthma & Immunology. 75(1). 19–21. 12 indexed citations
17.
Blaiss, Michael S.. (1992). Topical Corticosteroids in the Treatment of Pediatric Asthma. Pediatric Asthma Allergy & Immunology. 6(4). 227–232. 1 indexed citations
18.
Blaiss, Michael S.. (1992). Latex Allergy in Children: A Review. Pediatric Asthma Allergy & Immunology. 6(2). 71–75.
19.
Blaiss, Michael S., et al.. (1990). Proving penicillin allergy. Postgraduate Medicine. 87(2). 33–41. 9 indexed citations
20.
Blaiss, Michael S. & Richard D. deShazo. (1988). Drug Allergy. Pediatric Clinics of North America. 35(5). 1131–1147. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Oppenheimer Breakdown of academic impact, for papers by Roy Gerth van Wijk Breakdown of academic impact, for papers by Gianenrico Senna Breakdown of academic impact, for papers by Fulvio Braido Breakdown of academic impact, for papers by Robert A. Barbee Breakdown of academic impact, for papers by Eli O. Meltzer Breakdown of academic impact, for papers by E. Rand Sutherland Breakdown of academic impact, for papers by Cheryl M. Salome Breakdown of academic impact, for papers by Gary S. Rachelefsky Breakdown of academic impact, for papers by Agustin Calatroni
Rankless by CCL
2026